The short version of peptide mapping fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-20 and is reviewed periodically as new material appears.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
| Property | Value | Notes |
|---|---|---|
| Research code | PT-141 | Used in early literature before the generic name became common |
| Generic name | Bremelanotide | International nonproprietary name |
| Peptide class | Cyclic heptapeptide | Seven residues joined by a lactam bridge |
| Primary receptor | MC4R | Lower affinity reported at MC1R, MC3R and MC5R |
| Route studied clinically | Subcutaneous injection | Intranasal route was abandoned after pressor effects |
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
Lyophilized peptide arrives as a white to off-white cake or powder and is normally held at minus twenty degrees Celsius or colder for extended periods. Short-term bench work at ambient temperature is tolerable for minutes, not hours, because the solid is hygroscopic and picks up moisture that promotes hydrolysis. Vials should stay in a desiccator or a sealed bag with desiccant, protected from light, since aromatic residues in the sequence are susceptible to photo-oxidation. Inventory records that note arrival date and storage location reduce the chance of using degraded material.
Reconstitution is usually performed with sterile water or a dilute acetic acid solution, and the choice of solvent affects both dissolution speed and final pH. Complete dissolution should be confirmed by visual inspection before any aliquot is taken, since undissolved particles can concentrate in the sampling volume. Repeated freeze-thaw cycles are the most common cause of gradual loss of purity, so dividing a stock into single-use aliquots at the first opportunity is standard practice. Working solutions kept refrigerated are generally used within days rather than weeks.
Across literature and commercial listings, the substance appears under several names, including bremelanotide, PT-141, and various brand designations. A CAS registry number provides a unique identifier for the compound, aiding retrieval from chemical databases. Synonym lists may also contain early development codes and descriptive chemical names. When consulting sources, researchers need to confirm that the cited names refer to the same molecular structure to avoid confusion. Naming consistency matters especially when comparing analytical data across publications.
PT-141 is a synthetic cyclic heptapeptide whose development code is bremelanotide. It belongs to the class of melanocortin receptor agonists and acts by mimicking endogenous peptide hormones. The compound originated from research on melanotan II, where investigators exploring derivatives found distinct pharmacological features. Unlike the parent compound, PT-141 showed effects on pathways related to sexual desire and function in early studies, prompting its development as a separate candidate. Its molecular design aimed to separate receptor activity from pigmentary effects.
The molecular backbone consists of seven amino acid residues joined into a ring through a disulfide bridge. This cyclic conformation is critical for receptor binding. The sequence includes an acetylated N-terminus and an amidated C-terminus, modifications that improve resistance to enzymatic breakdown. One residue is in the D-configuration, a feature that further stabilizes the peptide against protease activity. Together, the ring structure and specific stereochemistry determine selectivity among melanocortin receptor subtypes.
The lyophilised solid is relatively stable when kept dry, protected from light and held at reduced temperature, commonly minus 20 degrees Celsius or lower for long-term storage. In solution the peptide is more vulnerable: tryptophan oxidation, hydrolysis of the lactam bridge and aggregation all become relevant over time, and the rate depends on pH, buffer composition and concentration. Repeated freeze-thaw cycles are generally avoided because they promote aggregation. Aqueous working solutions are typically prepared fresh or split into single-use aliquots to limit degradation before analysis.
Published studies differ in design, population and endpoint definition, so results are not always directly comparable across reports. Some trials used patient-reported measures of desire and distress, while others tracked physiological or behavioural outcomes. Questions that remain open include the durability of effects beyond short follow-up periods, the frequency of transient blood pressure elevation observed after administration, and whether a subtype-selective analogue could separate central effects from pigmentation-related activity. These points are usually framed as unresolved rather than settled in review literature.
Routine characterisation of bremelanotide relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nm, where the peptide backbone absorbs. Mass spectrometry, typically in tandem mode with electrospray ionisation, confirms identity and supports quantification in biological matrices. Additional checks include amino acid analysis, peptide mapping after enzymatic digestion, and confirmation of the lactam bridge, since incomplete cyclisation produces a mass-shifted by-product. Purity values above 95 percent are common in reference-grade material, though reports vary in how strictly related substances are resolved from the parent peak.
== Impact on victims == Corrective rape and other accompanying acts of violence can result in physical and psychological trauma, mutilation, unwanted pregnancy, and may contribute to suicide. Corrective rape is a major contributor to HIV infection in South African lesbians. In South Africa, approximately 10% of lesbians are HIV positive, with corrective rape being the most likely cause. HIV in South Africa is an epidemic, and due to homophobia, there is a lack of education about sexually transmitted diseases among lesbians. Homophobic laws and discrimination in South Africa contribute to the poor quality of health care for minorities. The psychological effects of corrective rape on victims can be detrimental. Many victims in countries such as South Africa and India where corrective rape is most prevalent suffer from a strong sense of insecurity and disempowerment due to strong homophobia in their communities. However, violence against the LGBTQ community in South Africa is seldom reported. Many survivors of corrective rape suffer from triple discrimination for being women, Black, and homosexual. This is especially true in South African townships, where corrective rape is common for lesbian women. Corrective rape victims may suffer from depression, anxiety, and/or post-traumatic stress disorder. Due to racial and sexual discrimination in health care, victims must often deal with these issues on their own.
A main supply valve with non-return valve, which supplies gas to the main gas supply hose of the umbilical. This is usually a quarter-turn valve, as it must be quick to operate and obvious whether it is open or closed. A pneumofathometer supply valve, which supplies gas to the pneumofathometer for the diver. This valve is usually near the main supply valve but with a different handle. It is usually a needle type valve as it must be finely adjustable, but it must also be large enough to allow a fairly high flow rate, as the air may be used as an alternative breathing air source, or to fill small lift bags. A pneumofathometer gauge is connected to the pneumo line. This is a high resolution pressure gauge calibrated in feet sea water (fsw) and/or metres sea water (msw). and is used to measure the depth of the diver by allowing air to flow through the pneumo hose and out the end attached to the diver. When the air supply is shut off, and the flow stops, the gauge indicates the pressure at the open end at the diver. Each pneumofathometer gauge has an overpressure valve to protect it against gas supply at higher pressure than it is designed to take. This is essential as the main supply pressure is significantly higher than the maximum depth pressure on the pneumo gauge. There is also often a snubbing valve or orifice between the pneumo line and the gauge to restrict flow into the gauge and ensure that the overpressure valve can adequately relieve the pressure.
The Canadian Society for Mass Spectrometry is an organization that promotes mass spectrometry in Canada. The goal of the society is to stimulate interest and collaborations in the Canadian mass spectrometry community. The society organizes conferences, awards prices and runs an online job board. The society is an affiliate society of the International Mass Spectrometry Foundation. Its current president is Derek Wilson. The society awards the annual Fred P. Lossing Award.
=== May === May 1 Iran war: President Donald Trump notifies lawmakers in Congress that the Iran war has been "terminated" ahead of a 60-day deadline under the War Powers Resolution which military operations must halt unless lawmakers authorize military force. 2026 May Day protests: May Day protests are held across the U.S., including an economic blackout as part of 3,500 "May Day Strong" events across the country. Additionally, demonstrations are held outside institutions such as the New York Stock Exchange. British singer Zayn Malik cancels all U.S. concert events for his upcoming Konnakol tour after being hospitalized for an unknown illness. May 2 2026 Kentucky Derby: In horse racing, American racehorse Golden Tempo wins the 152nd Kentucky Derby after entering the race with a 24–1 odds, making Cherie DeVaux the first female trainer to win the derby. Spirit Airlines announces it has gone out of business after 34 years. May 3 – Iran war: President Trump announces Operation Project Freedom in an effort to secure commercial traffic across the Strait of Hormuz. May 4 Iran war: The U.S. Central Command confirms the launch of Operation Project Freedom in an effort to secure commercial traffic across the Strait of Hormuz. Danish shipping company Maersk reports that the Alliance Fairfax, a US-flagged vehicle carrier operated by subsidiary Farrell Lines, has successfully crossed the Strait of Hormuz accompanied by U.S. military assets as part of Project Freedom. Iran is reported to have fired missiles and drones at military and commercial ships.
In 1996, the Stony Brook group trapped 3000 atoms in their MOT, which was enough for a video camera to capture the light given off by the atoms as they fluoresce. Francium has not been synthesized in amounts large enough to weigh.
Sources: en.wikipedia.org
Caitlin gave birth to their third child, a boy named Colm Garan Hart, on 25 July 1949. In October, the New Zealand poet, Allen Curnow, came to visit Thomas at the Boat House, who took him to his writing shed and "fished out a draft to show me of the unfinished Under Milk Wood" that was, says Curnow, titled The Town That Was Mad. This is the first known sighting of the script of the play that was to become Under Milk Wood.
More generally, an NAD(P)H-hydrate epimerase (EC 5.1.99.6, NAD(P)HX epimerase) is a type of enzyme with systematic name (6R)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide 6-epimerase. Enzymes of this class, especially NAXE and its orthologs, catalyse the following chemical reaction
=== Fortification === The World Health Organization does not have any recommendations for food fortification with vitamin E. The Food Fortification Initiative does not list any countries that have mandatory or voluntary programs for vitamin E. Infant formulas have alpha-tocopherol as an ingredient. In some countries, certain brands of ready-to-eat cereals, liquid nutrition products, and other foods have alpha-tocopherol as an added ingredient.
Kiana Fitzgerald of Consequence also praised the album's guest performances and lyrical versatility ("The brothers are as contemplative as they are comedic") and complimented the production, highlighting "M.T.B.T.T.F."'s specifically as evoking the golden era of hip-hop. Simon Vozick-Levinson of Rolling Stone gave the album four stars out of five, praising Clipse's "fascinating" emotional growth, but noting that it at times felt like a Pusha T solo album rather than a Clipse album. In an unrated positive review for Variety, Peter A. Berry praised the duo's chemistry, but criticized Williams's contributions, describing the album's production as "somewhat unimaginative" and his choruses on "So Far Ahead" and "By the Grace of God" as "ham-fisted tropes". Jordan Darville of The Fader called the album a "daring move" and a "solid, occasionally brilliant project" with an emotional core around Malice's Christian faith, praising the "grand" instrumentals and Clipse's more introspective lyrics than previous releases, while feeling that the features were more of a mixed bag, specifically criticizing "All Things Considered" for Williams and The-Dream's contributions. Marko Djurdjić of Exclaim! gave the "hostile, paranoid, and often inspiring album" a seven out of ten, praising the overall style of the rapping ("This is fucking rapping, and it is relentless.") and the "beyond impressive" writing while criticizing the flows as repetitive and describing the production on some tracks as "tedious [and] unnecessary".
In 1988, Bio-Synthesis helped in the synthesis and characterization of a new class of peptides with novel antimicrobial properties discovered at the NIH. In 1989, OCS became incorporated as Bio-synthesis, Inc. and moved its laboratories to Lewisville, Texas. In 1993, Bio-Synthesis was one of the first peptide synthesis companies to acquire a Finnigan MALDI-TOF mass spectrometer for the accurate quality control of synthetic peptides produced in-house. In 1994, Bio-synthesis pioneered the use of molecular methods for HLA analysis which is applied in organ matching for transplantation purposes. Later in the same year Bio-Synthesis held the first major HLA DNA typing workshop with the attendance of HLA laboratory directors from around the country in conjunction with University of North Texas in Denton Texas.
Sources: en.wikipedia.org
The code designates bremelanotide, a cyclic heptapeptide melanocortin receptor agonist. It served as an internal research identifier before the compound entered formal clinical development. The code and the generic name refer to the same molecule.
MC4R is generally described as the principal target, based on binding affinity and functional assays. Activity at MC1R, MC3R and MC5R is reported as weaker. Receptor selectivity is one reason the compound was pursued for central rather than vascular effects.
Both are synthetic melanocortin analogues built on a similar cyclic peptide scaffold. Bremelanotide is described in the literature as a metabolite-derived analogue of melanotan II rather than the same substance. The two differ in terminal modifications, which affect half-life and receptor profile.
It is a synthetic cyclic peptide that activates melanocortin receptors. It is given by injection and was approved in the United States in 2019 for a specific low-desire diagnosis in premenopausal women. It is not a hormonal therapy.